- Home
- VRDN vs CDRE Comparison
VRDN vs CDRE Comparison
Compare VRDN & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- CDRE
- Stock Information
- Founded
- VRDN 2006
- CDRE 2012
- Country
- VRDN United States
- CDRE United States
- Employees
- VRDN N/A
- CDRE N/A
- Industry
- VRDN Medical Specialities
- CDRE Industrial Specialties
- Sector
- VRDN Health Care
- CDRE Health Care
- Exchange
- VRDN Nasdaq
- CDRE Nasdaq
- Market Cap
- VRDN 1.5B
- CDRE 1.3B
- IPO Year
- VRDN N/A
- CDRE 2021
- Fundamental
- Price
- VRDN $18.13
- CDRE $38.17
- Analyst Decision
- VRDN Buy
- CDRE Buy
- Analyst Count
- VRDN 12
- CDRE 5
- Target Price
- VRDN $36.44
- CDRE $39.75
- AVG Volume (30 Days)
- VRDN 1.6M
- CDRE 322.5K
- Earning Date
- VRDN 02-25-2025
- CDRE 03-04-2025
- Dividend Yield
- VRDN N/A
- CDRE 0.92%
- EPS Growth
- VRDN N/A
- CDRE N/A
- EPS
- VRDN N/A
- CDRE 0.83
- Revenue
- VRDN $302,000.00
- CDRE $516,159,999.00
- Revenue This Year
- VRDN $2.55
- CDRE $19.08
- Revenue Next Year
- VRDN N/A
- CDRE $8.30
- P/E Ratio
- VRDN N/A
- CDRE $46.12
- Revenue Growth
- VRDN N/A
- CDRE 7.18
- 52 Week Low
- VRDN $11.40
- CDRE $29.19
- 52 Week High
- VRDN $27.20
- CDRE $40.28
- Technical
- Relative Strength Index (RSI)
- VRDN 44.39
- CDRE 72.96
- Support Level
- VRDN $16.60
- CDRE $31.56
- Resistance Level
- VRDN $21.58
- CDRE $32.72
- Average True Range (ATR)
- VRDN 1.00
- CDRE 1.08
- MACD
- VRDN -0.16
- CDRE 0.60
- Stochastic Oscillator
- VRDN 30.72
- CDRE 96.31
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.